Project Grant R21NS145545

Award Date 7/1/25
Completion Date 6/30/27
Dollars Obligated $430K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders provides $532,381 to Emory University to comprehensively investigate the molecular mechanisms underlying the role of the KIF5A gene variant KIF5ADE27 in the pathogenesis of amyotrophic lateral sclerosis (ALS). The key research objectives include: 1) determining the gain-of-function effects of KIF5ADE27...
This $535,743 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at the University of Wisconsin-Madison to investigate the mechanisms controlling cargo transport and localization in developing sensory neurons. The key objectives are to: Determine the mechanisms by which the kinesin light chain 4 (KLC4) protein regulates axon...
This $195,570 federal Project Grant award was made by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research by The Regents of the University of California, San Francisco (UCSF) to investigate the role of the molecular co-chaperone DNAJC7 in preventing the aggregation of misfolded proteins associated with neurodegenerative diseases such as...
This federal Project Grant award of $897,250 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research focused on understanding the role of biomolecular condensates, such as ribonucleoprotein (RNP) granules, in governing RNA metabolism and their relationship to neurological diseases. The 8-year research program, led by St. Jude Children's Research Hospital...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research focused on understanding the role of the KIF5A gene in amyotrophic lateral sclerosis (ALS). The award of $121,554 to the University of California, San Diego (UCSD) will fund a research project with three key objectives: (1) investigating the impact of KIF5A ALS mutations...
Emory University received a $430,375 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant supports research to elucidate the subcellular dynamics of ubiquitination, a key biological process regulating synaptic function and neuronal health, using advanced single-molecule imaging techniques. The research aims to uncover new mechanisms by...
This Project Grant award of $270,434 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research by The Trustees of Princeton University to investigate the spatiotemporal regulation of mRNA and its role in neuronal remodeling during morphogenesis. The key goals are to: 1) characterize the localization and motility of the chickadee (chic) mRNA transcript...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services, awarded a $4,528,840 Project Grant to The Salk Institute For Biological Studies under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The three-year award beginning August 19, 2022 will fund research to functionally dissect cerebellar output circuits that orchestrate limb motor control. Specifically, the grantee will...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Emory University a $430,375 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to study disease-associated mutations and ligand activation of the adhesion G protein-coupled receptor ADGRB2. The key objectives are to: Investigate newly identified patient mutations in the ADGRB2 gene that are associated with spastic paraparesis and other neurological symptoms,...

This federal Project Grant award of $430,375.00 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research at Emory University to investigate the role of the kinesin-3 motor protein KIF1C in regulating RNA transport and localization in neurons. The goal is to develop a human neuronal disease model for hereditary spastic paraplegia type 58 (SPG58), a neurological disorder caused by KIF1C mutations, in order to identify KIF1C-associated RNA-binding proteins and their mRNA targets that are dysregulated in this condition. The proposed research aims to elucidate the mechanisms by which altered KIF1C transport dynamics affect mRNA localization in neurons and contribute to the pathogenesis of SPG58, with potential implications for understanding and treating other neurodegenerative diseases involving disruptions in RNA transport processes.

Generated 7/15/25, 9:24 AM